arBtrage CAPITALIZING MARKETS checking… Sign in

Capricor Therapeutics, Inc.

CAPR Health Care Biotechnology: Pharmaceutical Preparations
$26.71
▼ -4.4% Today
as of Jun 7, 06:55 ET
Last 30 days -21.39% Apr 28 → Jun 05
$26.10 $28.32 $30.55 $32.77 $34.99 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$27.88
High
$27.95
Low
$26.56
Volume
$573,776
Avg Vol
$2M
Mkt Cap
$1.7B
P/E (TTM)
Beta
52w High
$40.37
52w Low
$4.30
Div Yield
Shares Out
$58M

Overview

52-week range
$4.30
$40
62% of range
Avg surprise (last 2)
-33.9%
Avg reaction (last 2)
+0.7%
50% positive
Latest IV / EM
107%
EM ±14.9% · $27 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.59$-0.51$-0.42$-0.33$-0.25 Actual $-0.29Actual $-0.25Actual $-0.31Actual $-0.35Actual $-0.38Actual $-0.53Est $-0.33Actual $-0.57Actual $-0.54Actual $-0.59Est $-0.55 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-34M$-24M$-15M$-5M$4M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.59 $-0.55 -7.3% -11.3% -1.2% earnings
Tue Sep 30, 2025Sep 2025 $-0.54 financials
Mon Jun 30, 2025Jun 2025 $-0.57 financials
Tue May 13, 2025Mar/2025 $-0.53 $-0.33 -60.6% +2.7% earnings
Mon Sep 30, 2024Sep 2024 $-0.38 financials
Sun Jun 30, 2024Jun 2024 $-0.35 financials
Sun Mar 31, 2024Mar 2024 $-0.31 financials
Sat Sep 30, 2023Sep 2023 $-0.25 financials
Fri Jun 30, 2023Jun 2023 $-0.29 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$2M$4M
Cost of revenue
Gross profit
Operating income$-37M$-26M$-28M$-25M$-13M$-12M
Net income$-34M$-25M$-26M$-24M$-13M$-11M
EPS (diluted)$-0.59$-0.54$-0.57$-0.53$-0.38$-0.35

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$105M$288M$20M$23M$29M$11M$68M$11M
Inventory
Total current assets$283M$323M$101M$124M$146M$163M$86M$31M
Total assets$326M$356M$126M$134M$154M$170M$93M$38M
Long-term debt
Total liabilities$48M$50M$43M$29M$26M$25M$25M$27M
Total equity$279M$306M$84M$105M$128M$145M$68M$12M

Implied volatility — last 90 days

102%104%107%109%112% Jun 07 — IV 107% · EM ±14.9%

Sector peers